Myocardial Infarction With Non-Obstructive Coronary Arteries in the Greek Population (NCT04186676) | Clinical Trial Compass
CompletedNot Applicable
Myocardial Infarction With Non-Obstructive Coronary Arteries in the Greek Population
Greece60 participantsStarted 2021-01-01
Plain-language summary
The MINOCA-GR registry will be the first nationwide study aiming to obtain data regarding prevalence, demographics, clinical profile, previous anginal status, presence of cardiovascular risk factors, management and outcomes in patients with Myocardial Infarction with Non-Obstructive Coronary Arteries. An additional purpose of the registry is to highlight, for the first time worldwide to the best of the investigator's knowledge, the role of cardiac computed tomography angiography for risk stratification and personalized therapeutic approach in MINOCA patients.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Patients older than 18 years
. Patients without known history of coronary artery disease
. Patients with acute coronary syndrome with and/or without ST-segment elevation who underwent coronary angiography within 24h after onset of the disease
. Absence of obstructive coronary atherosclerosis (normal coronary arteries or plaques \<50% stenosis) based on the results of invasive coronary angiography
. Subject has provided written informed consent
. Subject is willing to comply with study follow-up requirements
Exclusion criteria
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Frequency of post-MI angina [Seattle Angina Questionnaire (SAQ)]
Timeframe: 1 month
2
Frequency of post-MI angina [Seattle Angina Questionnaire (SAQ)]
Timeframe: 6 months
3
Frequency of post-MI angina [Seattle Angina Questionnaire (SAQ)]
Timeframe: 12 months
4
Extent of coronary atherosclerosis
Timeframe: 15 days after the acute event
5
Extent of coronary atherosclerosis using Leiden CTA risk score
Timeframe: 15 days after the acute event
6
Extent of coronary atherosclerosis using Gensini score